KORANEX CAPITAL has a total of 14 patent applications. Its first patent ever was published in 2019. It filed its patents most often in United States, WIPO (World Intellectual Property Organization) and Australia. Its main competitors in its focus markets pharmaceuticals and organic fine chemistry are GUANGDONG LITAI PHARMACEUTICAL CO LTD, SUN HONGZHI and RADIOMEDIX INC.
# | Country | Total Patents | |
---|---|---|---|
#1 | United States | 4 | |
#2 | WIPO (World Intellectual Property Organization) | 2 | |
#3 | Australia | 1 | |
#4 | Brazil | 1 | |
#5 | Canada | 1 | |
#6 | China | 1 | |
#7 | EPO (European Patent Office) | 1 | |
#8 | Israel | 1 | |
#9 | Republic of Korea | 1 | |
#10 | Singapore | 1 |
# | Industry | |
---|---|---|
#1 | Pharmaceuticals | |
#2 | Organic fine chemistry |
# | Technology | |
---|---|---|
#1 | Medical preparations | |
#2 | Sugars | |
#3 | Therapeutic chemical compounds |
# | Name | Total Patents |
---|---|---|
#1 | Shiao Tze Chieh | 12 |
#2 | Roy Rene | 8 |
#3 | Roy René | 4 |
#4 | Mignani Serge | 3 |
#5 | Moffett Serge | 3 |
#6 | Tze Chieh Shiao | 1 |
#7 | René Roy | 1 |
Publication | Filing date | Title |
---|---|---|
US2021085770A1 | Neoglycoconjugates as vaccines and therapeutic tools | |
SG11202009113PA | Precision glycoconjugates as therapeutic tools |